A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol

NCT01263197 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY2216684
DRUG: albuterol
DRUG: propranolol
DRUG: placebo for LY2216684
DRUG: placebo for albuterol
DRUG: placebo for propranolol

Sponsor

Eli Lilly and Company